Business Wire

1. Agilent To Acquire Proscia, Advancing AI-Enabled Digital Pathology And Scientific Intelligence 10/13/2026

   Agilent Technologies Inc. today announced it has entered into a definitive agreement to acquire Proscia, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240M in cash at closing and up to an additional $30M based on achieving future performance milestones.

2. Fujifilm Launches Synapse Pathology v3.0, Advancing The Digital Pathology Experience With Expanded AI Capabilities 10/12/2026

   FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, today announced the launch of Synapse Pathology v3.0.

3. VITALiS Selects Applied BioCode As Preferred Solution Provider For Molecular Gastrointestinal Pathogen Panel Testing 10/12/2026

   VITALiS and Applied BioCode today announced an expanded collaboration to support the adoption and internalization of gastrointestinal (GI) pathogen testing in commercial and physician office laboratory settings.

4. Clinisys Moves Beyond Document Management To Laboratory Document Intelligence 10/7/2026

   Clinisys, a global leader in laboratory informatics, today announced the expansion of its innovation portfolio with integrated document intelligence capabilities in Clinisys Laboratory Solution (CLS), helping laboratories capture, govern, search, and activate information across scientific and operational workflows while advancing Clinisys's vision of connected laboratory intelligence.

5. Invivoscribe Advances Molecular Clonality Testing Portfolio With Comprehensive LymphoTrack Flex Suite 10/6/2026

   Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the complete LymphoTrack Flex suite, an integrated next-generation sequencing (NGS) solution to identify and track immunoglobulin and T-cell receptor gene rearrangements.

6. VB Spine Announces FDA Breakthrough Device Designation For New Blood Test Designed To Identify Patients At Risk For Scoliosis Progression 9/29/2026

   VB Spine LLC (“VB Spine”), the largest privately-held spine company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to ScolimiR-3D, an in vitro diagnostic blood test designed to assess the risk of disease progression in patients diagnosed with adolescent idiopathic scoliosis (AIS).

7. QIAGEN Launches QIAmini To Automate Small-Batch Sample Preparation 9/24/2026

   QIAGEN N.V. today announced the launch of QIAmini, a compact automated sample preparation system designed to give research laboratories a time-saving and cost-efficient alternative to processing samples by hand.

8. Countable Labs Sets A New Standard In Molecular Testing For Hematologic Malignancy Clinical Applications 9/24/2026

   Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, announced the company’s entry into the clinical market with its new Ancora assays for oncology applications.

9. Agilent Launches TapeStationDx Systems For Clinical NGS Sample Quality Control 9/21/2026

   Agilent Technologies Inc. today announced the launch of the Agilent 4150 TapeStationDx system, Agilent 4200 TapeStationDx system and Agilent TapeStationDx software, extending the company's automated electrophoresis portfolio into regulated clinical laboratory environments. 

10. Augurex Announces Mayo Clinic Laboratories Now Offering 14-3-3eta Testing For Rheumatoid Arthritis 9/15/2026

    Augurex Life Sciences Corp., a commercial-stage diagnostics company focused on autoimmune and inflammatory diseases, today announced that Mayo Clinic Laboratories is now offering 14-3-3eta serum testing for rheumatoid arthritis (RA) in the United States.